Matthew B. Yurgelun

机构：Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Cancer Genetics (United States), Dana-Farber Brigham Cancer Center · ORCID：0000-0002-6184-9273

发表论文 465 篇 · 总被引 7864 次 · h-index 42

代表论文

• Immune and stromal features of durable complete response to radiation and dual immune checkpoint blockade in pancreatic cancer (2026 · medRxiv)
• Impact of vitamin D on the colon cancer immune microenvironment: results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stage I-III colon cancer (2026 · Cancer Discovery)
• Data from A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance Study (2026)
• Supplementary Mats and Methods from A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance Study (2026)
• Beyond the Locus: Learning Tumor Microsatellite Instability Status From Genome and Transcriptome Sequencing (2026 · JCO Clinical Cancer Informatics)
• Supplementary Figure S1 from A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2 (2026)